Frequently asked questions
How the evidence grades work, what we will and won't answer, and what to do if something goes wrong. If your question is not here, get in touch — though note there are questions we will not answer, and dosing is one of them.
About this site
No. Genexis Health holds no stock, takes no orders and arranges no supply. There is no price list and no enquiry that leads to a sale. That is deliberate — an information resource with something to sell is an advertisement, and you would be right to read it as one.
At present we do not. There is no advertising, no sponsorship and no affiliate arrangement. If that ever changes it will be disclosed prominently on this page, because the absence of a commercial interest is the main reason to trust anything here.
No. We do not recommend, endorse or link to suppliers, and we cannot vouch for any of them. If a seller cites this site as a reference, they are doing so without our involvement.
No, and not if asked privately either. We describe what studies found, not how to use anything. For most compounds here no dose has been established as safe by anyone, so a figure would be a guess presented with false authority.
Because a lot of what is covered here is prescription-only medicine, investigational products, or compounds regulators have warned about. We would rather be clear up front that this is information rather than advice than bury it in a footer nobody reads.
Evidence and accuracy
Seven levels, from "approved medicine" down to "laboratory studies only", plus a separate grade for compounds tested in humans that failed. The grade reflects the best available human evidence — not the volume of literature, and not how promising something sounds. A thousand mouse papers is still animal evidence. The full scale is explained on the evidence page.
Because the grade describes human evidence. BPC-157 is the clearest example: an extensive rodent literature, and no published controlled human trial for anything it is discussed for. Over 90% of compounds that look promising in animals fail when tested in people, so the distinction matters more than the page count.
That the compound went into human trials and did not beat placebo on its primary endpoint, or development was discontinued. It sits below "animal only" deliberately — a failed trial is stronger evidence than no trial, it just points the other way. AOD-9604 and ipamorelin are both in this category.
You do not have to take our word for it, which is why every compound page links to the primary literature. Read the studies. If our summary does not match what you find, tell us.
Email us the compound and, where you can, the study you think we have misread. We will check it against the source and correct the page if you are right. Substantive corrections are noted on the page. This applies especially if you research in the field — we would rather be corrected than be confidently wrong in public.
Safety
That is not a question we can answer, and anyone who answers it confidently for a compound without human trials is guessing. What we can tell you is what has been reported, what has not been studied, and what regulators have said. Beyond that it is a conversation for a doctor who knows your medical history.
Contact emergency services now — 999 in the UK, or 111 for urgent advice that is not an emergency. Tell them exactly what you took. Clinicians treat people who have taken unapproved substances routinely and their concern is treating you, not reporting you. Withholding what you took is the most common way a manageable situation becomes a serious one.
Because people are already using them, and the alternative to an honest summary is not silence — it is whatever the sellers say. Melanotan II has published case reports of melanoma and rhabdomyolysis and carries an MHRA warning. Someone considering it is better served knowing that than not finding it.
No. A CoA attests to the purity of a specific batch. It says nothing about whether the compound is safe to use, nothing about sterility or endotoxin content, and nothing about whether the batch it describes is the one you received.
Practical
Yes, freely. Link to them, quote them, send them to someone weighing a decision. We only ask that you do not reproduce substantial portions commercially or present the content as medical advice.
Yes. If there is one you would like covered, tell us — particularly if it is something being heavily discussed with little reliable information available.
Discussion, questions and harm reduction — reading the literature, and what the evidence does and does not support. No selling, and no dosing advice there either.
Minimally, and not personally. Analytics come from Cloudflare Web Analytics, which sets no cookies and uses no cross-site identifier, so it cannot follow you elsewhere. We see totals — how many people read a page — not individuals. That is also why there is no cookie banner.
Information only. Everything on this site is a summary of published research, provided for general information. It is not medical advice, not a treatment recommendation, and not a substitute for consultation with a qualified healthcare professional. Genexis Health does not sell, supply or arrange the supply of any compound described here. Many of the compounds covered are prescription-only medicines, investigational products that no regulator has approved, or substances regulators have issued public warnings about. Nothing here should be read as suggesting any of them is safe or appropriate for you to use.
Still have a question?
Corrections, compounds you would like covered, or anything about how we have read a study.